Zydus On Acquisitions, $100m Specialty Biz Target, gAsacol Competition

No Revlimid Sales In Q2

 
• By Vibha Ravi
M&As As Part Of Growth Strategy
Acquisitions Are Part Of Zydus' Specialty Growth Strategy • Source: Shutterstock

More from Business

More from Scrip